Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Lupin Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	500257
ISIN Demat	INE326A01037
Book Value	531.58

NSE Code	LUPIN
Dividend Yield %	0.61
Market Cap	898634.64

P/E	22.62
EPS	86.99
Face Value	2


	BSE		NSE

02-Jul-2025

Last Price	1967.60
Net Change	6.3
% Change	0.32%
Prev.Close	1961.30
Open	1978.85
High	1984.05
Low	1943.60
Volume	44090

Last Price	1968.40
Net Change	7.5
% Change	0.38%
Prev.Close	1960.90
Open	1975.00
High	1984.00
Low	1942.70
Volume	1446106

Value	86834439
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1984.05
52-Week High	2403.45
52-Week Low	1614.90

Value	2846137225.1
Best Buy	1968.40
Best Sell	0.00
Best Quantity	198
Sell Quantity	0
Today's Range	1984.00
52-Week High	2402.90
52-Week Low	1615.00

Open Price	1970.10
High Price	1987.00
Low Price	1946.20
Last Price	1970.90
Prev Close	1961.30
Change	9.60
% Change	0.49 %

Average Price	1971.79
Underlying Value	1968.40
Number of contracts traded	6558
Turnover in Rs. Lakhs	54957
Open Interest	10792880.00
Change in O I	264350.00
% Change in O I	2.51 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	198
Price	1968.40

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	425
Price	1970.3

Quantity	1700
Price	1971.5

Holding Details

Latest Corporate Events

Bonus

1 : 1

11-Aug-06

Book Closure

05-Aug-20

12-Aug-20

Dividend

400 %

16-Jul-24

Company News

02-07-2025

Lupin gets USFDA’s nod fo...

02-07-2025

Lupin moves up on getting...

01-07-2025

Lupin executes BTA for tr...

01-07-2025

Lupin executes BTA for tr...

26-06-2025

Lupin launches Prucalopri...

25-06-2025

Lupin gets USFDA’s nod fo...

25-06-2025

Lupin rises on getting US...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.